Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs.
Schernthaner G, Karasik A, Abraitienė A, Ametov AS, Gaàl Z, Gumprecht J, Janež A, Kaser S, Lalić K, Mankovsky BN, Moshkovich E, Past M, Prázný M, Radulian G, Smirčić Duvnjak L, Tkáč I, Trušinskis K. Schernthaner G, et al. Among authors: smircic duvnjak l. Cardiovasc Diabetol. 2019 Aug 31;18(1):115. doi: 10.1186/s12933-019-0920-3. Cardiovasc Diabetol. 2019. PMID: 31472683 Free PMC article.
Perspectives of Patients with Insulin-Treated Type 1 and Type 2 Diabetes on Hypoglycemia: Results of the HAT Observational Study in Central and Eastern European Countries.
Haluzik M, Kretowski A, Strojek K, Czupryniak L, Janez A, Kempler P, Andel M, Tankova T, Boyanov M, Smircic Duvnjak L, Madacsy L, Tarnowska I, Zychma M, Lalic N. Haluzik M, et al. Among authors: smircic duvnjak l. Diabetes Ther. 2018 Apr;9(2):727-741. doi: 10.1007/s13300-018-0388-2. Epub 2018 Mar 9. Diabetes Ther. 2018. PMID: 29524189 Free PMC article.
SGLT2 inhibitors in T2D and associated comorbidities - differentiating within the class.
Schernthaner G, Drexel H, Moshkovich E, Zilaitiene B, Martinka E, Czupryniak L, Várkonyi T, Janež A, Ducena K, Lalić K, Tankova T, Prázný M, Smirčić Duvnjak L, Sukhareva O, Sourij H. Schernthaner G, et al. Among authors: smircic duvnjak l. BMC Endocr Disord. 2019 Jun 17;19(1):64. doi: 10.1186/s12902-019-0387-y. BMC Endocr Disord. 2019. PMID: 31208401 Free PMC article.
Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review.
Janež A, Guja C, Mitrakou A, Lalic N, Tankova T, Czupryniak L, Tabák AG, Prazny M, Martinka E, Smircic-Duvnjak L. Janež A, et al. Among authors: smircic duvnjak l. Diabetes Ther. 2020 Feb;11(2):387-409. doi: 10.1007/s13300-019-00743-7. Epub 2020 Jan 4. Diabetes Ther. 2020. PMID: 31902063 Free PMC article. Review.
Diagnostic challenges of diabetic kidney disease.
Vučić Lovrenčić M, Božičević S, Smirčić Duvnjak L. Vučić Lovrenčić M, et al. Among authors: smircic duvnjak l. Biochem Med (Zagreb). 2023 Oct 15;33(3):030501. doi: 10.11613/BM.2023.030501. Epub 2023 Aug 5. Biochem Med (Zagreb). 2023. PMID: 37545693 Free PMC article. Review.
Human complement component C3 N-glycome changes in type 1 diabetes complications.
Šoić D, Štambuk J, Tijardović M, Keser T, Lauc G, Bulum T, Lovrenčić MV, Rebrina SV, Tomić M, Novokmet M, Smirčić-Duvnjak L, Gornik O. Šoić D, et al. Among authors: smircic duvnjak l. Front Endocrinol (Lausanne). 2023 May 24;14:1101154. doi: 10.3389/fendo.2023.1101154. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37293493 Free PMC article.
The influence of dopamine-beta-hydroxylase and catechol O-methyltransferase gene polymorphism on the efficacy of insulin detemir therapy in patients with type 2 diabetes mellitus.
Bozek T, Blazekovic A, Perkovic MN, Jercic KG, Sustar A, Smircic-Duvnjak L, Outeiro TF, Pivac N, Borovecki F. Bozek T, et al. Among authors: smircic duvnjak l. Diabetol Metab Syndr. 2017 Dec 4;9:97. doi: 10.1186/s13098-017-0295-0. eCollection 2017. Diabetol Metab Syndr. 2017. PMID: 29225702 Free PMC article.
30 results